{"id":998649,"date":"2026-08-27T16:08:40","date_gmt":"2026-08-27T20:08:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-08-27T16:08:40","modified_gmt":"2026-08-27T20:08:40","slug":"vaxcyte-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"Vaxcyte to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN CARLOS, Calif., Aug.  27, 2026  (GLOBE NEWSWIRE) &#8212; Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in fireside chats and host one-on-one meetings at the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Wells Fargo 21<\/strong><br \/>\n          <sup><br \/>\n            <strong>st<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Healthcare Conference, September 8-10, 2026: <\/strong>Fireside chat will take place on Tuesday, September 8 at 3:00 p.m. ET \/ 12:00 p.m. PT.<\/p>\n<\/li>\n<li>\n          <strong>Cantor Global Healthcare Conference, September 9-11, 2026: <\/strong>Fireside chat will take place on Wednesday, September 9 at 2:45 p.m. ET \/ 11:45 a.m. PT.<\/li>\n<\/ul>\n<p>A live webcast of the fireside chats will be accessible through the Investors &amp; Media section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bs6TKqxPU7ipXhFGUL_cEiHtL8L7cguD88HY9vTLAVKcEMZWrALFtw-jt7psjbIDBsbMot_gh_vyyntFKhLkWgJOGVGWv_Y6fDAfr5Q_qeQBzZxKOL_yHOF037GKGNLP\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.vaxcyte.com\/<\/a> for approximately 30 days following each conference.<\/p>\n<p>\n        <strong>About Vaxcyte\u00a0<\/strong><br \/>\n        <br \/>Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate being evaluated in the OPUS Phase 3 adult clinical program and in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-31 and VAX-24 are designed to improve upon standard-of-care PCVs by covering the serotypes in circulation that cause a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains. VAX-XL, in earlier-stage development, also leverages the Company\u2019s carrier-sparing, site-specific conjugation technology with the aim of further expanding coverage to deliver the broadest-spectrum candidate in the Company\u2019s PCV franchise.<\/p>\n<p>VAX-A1 is a prophylactic vaccine candidate designed to provide broad, strain-independent protection against disease caused by Group A Strep and is currently being evaluated in a Phase 1 clinical study in adults. Group A Strep remains a significant global cause of morbidity and mortality across both adult and pediatric populations and is a leading driver of antibiotic use, underscoring the substantial public health burden.<\/p>\n<p>Vaxcyte is re-engineering the way highly complex vaccines are made through XpressCF<sup>\u00ae<\/sup>, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company\u2019s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to develop high-fidelity vaccines with enhanced immunological benefits. Vaxcyte\u2019s pipeline also includes VAX-GI, a vaccine candidate designed to prevent Shigella. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hi1ujxji5mqvlEQC7oS2925zlPycjfYNUk2zNrq2cT2pZe44OermkYAJ1hRhB1oQJjN3q99xn-bcUZoFvZMjgVyMj49HXXRoJ1tG-5bVzZedUNMkH-n_nLyRPksttSKPjzSOtjotZDaOnu0nRJq7DP2Hnv9wxNdXGGLog20pnfvyeRAi5zfnwrNg4Bi0I3-H_ZCrJjlt_tFO6gloG48BiOvUoY-9Oe9zhO5r9Zps8bweVOROGuSf8uOgELQguDGzKMJhpbfM7KWd6MjcytsBqN-RDCyz4Y_sGNerV2UgP-8KeDBc0njLCuAndGZpg2ysU9y2MGyDJiaQd9L6oDkJNg8c6smuMrhZBs6meF4YcN9AhQRBMsKq95Vo-aRGMfNPtmCduf86J8ywsEbfLZBxsVwl_3Pg56Jj0TqIVnrr4pEjhTZM0PU5Pss40Dc1ohkST3Xt0YJkdfDZAxYEBjxNLYutwkqzoI-qVUck95JNZHqAImnx1fowwpNm5vY3c81QosxvAvmP3zFb0YXCsqZfut1FAvxJX6Ds8GMVPUs4G-yqt9PrTnIypSlxPlWzcezC5FzhwAsCTG2EveGTts0w7x-bj8_jdvPJUM4S-MeAJkKRFNZ8Xm2mgJFuqQelBe6z-RBEbkI5OmkPRMrn84zqOx_IJNglVXRizHWU6vxXNXHycforSL1M5LEdzjgfeyS0MQKH7zaPChwsKQ6MIA2jm4ibVMCmelSejqIyHs4brzP-HyyBIQfZIZGR1DDHW6GkHlf_wG2EveR2UwR9JTMlrLUeBTNCeZYhZsW2OOLK5qH9MjxWp70TgCuucYdVlYQIMktj6517hYoGc1nwsUM1ODNYqHYp1XxAXtaqEazTjNWgUC2OmlqhgzEWkqlOyGfiRwHSyiljlWNDNW6-_uJjgvixIo4aD8utc-QrwytGD27W6lXPCaM6hv2ttQfTKgpLatSdKuj6P7NR43ITUYZrT4VUPNzTT5-wFvfqF--dAtpTMaWwJO-wUFc8WH5GJU-UGcGiVBc4Y2qJt_LXM42YcPkG2zalnGYAu7KHi4LzS-c1S1PLRZVZgn4gxFjAlmL8x35p3up5us6GkLYNWfbRt1bMjxQVz9hhYr1QJYSn5VTXdHwwCsPBhbANNDaejFm7oBT4jEwv-0-PNhZRwRhTePgzZ7n-Ma_pPbfeGC7ocizTE3HZQxzR4DALfkhUETWYA3sbeESRhv0Aoremg0IVn-3nXvH1LWp18xS2MfV_J-fZdBu6LrLKFRoInp3BxQ6A8QgW14g02tenItATjbwb0zBUPa9q407e_vv6cYFGT2kucglyOPWBFWViFW51fjGRfpBlkmWvyidABHRjylqenmLFj4x6KzbL0Hj1zz_p-WbjbgN-CycGioNJEbRGrkdbXgIDfL_jFL_FDafMTs1Qu3NkDVt5FjqFhuxgpUxCE63AqWmFS3Uf4JAruTVfWY1VZPk4RecxgtvY-KLKgZVziwepERY8OO2iWuVvsZkGxA3mUoAUkyMEGSTeWn3EzPeDuXi9mxKhDd439o21eMim57PHb_wb7_Uckfaa3cbtA9APiAjv9Sk0fdNHjUKAA-_tM33DLaK8FM6LyM9QQryearRauvEYzvI7r6dHEFLW4iMz-qpqPQeyEtd418wCD2PXb55wYxbdCa2BcAYcF9h45DCJyEE2hXXS2S9XrCodPfwg0OW4odugSWtMcYSA-Bg0BXF-zq3ECWkGmqfwoYb8CXnLkYtCjMhyssQPFDATaWy_jYsfWN-lTW3YHbqwMT9ntRrprgakLsBtnUMeJZwPmhY-96HPQ0eP6E-qYhRk8VbT9kIvSrdfJtXk_Z8iWI1SGerjG72FxMzJPVlUlrMkFyv_6LriAZvljOWOmeXelAmIlA1VIU-pYwQqaZjlRthMBDLyPeI7VJ7O0qEXaR0h8ixAQrmMPEaAjlkBePrOhY4u2VpXaJkOgnqYEBd6-itrfclHYqvoPcZVjtBVbZGVA3pwjEMiqE0470RISDthx4d-gXVetptO3D2tohy73jJZZ7TFMw1cSqm76ffrzReQN-PUKYR5kf65STiCuwvjcxLU9MadET1slhmcYBo3ez776giV4d7P-mBmTshsqu6-as5cuFoeAiN6RjYSwYskdd9ipBmIn-O7oHsrMremDYfF-cBI-29ZcKl_U9kQGXnn04JOWTpP3vU_Twhmu8_RgpWVZZZyjk38POPZmXcvK9so\" rel=\"nofollow\" target=\"_blank\">www.vaxcyte.com<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>Contact:<\/u><br \/>\n        <\/strong><br \/>\n        \n      <\/p>\n<p>Jeff Macdonald, Executive Director, Investor Relations<br \/>Vaxcyte, Inc.<br \/>917-371-0940<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=naPZjHnVkR_UGMOE95AZ7if6ZLpOdYe7BZlQqHrkeo0ZgYXqFNrEBvkmADYp4rsKTPn_FbsSQFsn9x3FHvQNGCKeuHOPYqFaneUXx5hki97hVIfmll3ZmCDEmbut1SlrelPtt7SnXi9Z4IZTPkSnypp9MI7HJ0gQXEQdrXYFR6wlXBMNg8RkDCfV6boEF_3-81Jebu1JE-kPTHi_3zRTnJL5nmwzdpkubxILJdGfzxTX_LIPEhbSvGY-D9b95duKKGEpAi77A58nre7aXtxo8g==\" rel=\"nofollow\" target=\"_blank\">investors@vaxcyte.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDBiODY1Y2UtY2NmMy00NWQxLWE3Y2EtZTk3NzhiOThjMjJmLTEyMDczNzctMjAyNi0wOC0yNy1lbg==\/tiny\/Vaxcyte-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN CARLOS, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in fireside chats and host one-on-one meetings at the following investor conferences: Wells Fargo 21 st Annual Healthcare Conference, September 8-10, 2026: Fireside chat will take place on Tuesday, September 8 at 3:00 p.m. ET \/ 12:00 p.m. PT. Cantor Global Healthcare Conference, September 9-11, 2026: Fireside chat will take place on Wednesday, September 9 at 2:45 p.m. ET \/ 11:45 a.m. PT. A live webcast of the fireside chats will be accessible through the Investors &amp; Media section of the Company&#8217;s website at https:\/\/investors.vaxcyte.com\/ for approximately 30 days following each conference. About Vaxcyte\u00a0 Vaxcyte &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vaxcyte to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998649","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN CARLOS, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in fireside chats and host one-on-one meetings at the following investor conferences: Wells Fargo 21 st Annual Healthcare Conference, September 8-10, 2026: Fireside chat will take place on Tuesday, September 8 at 3:00 p.m. ET \/ 12:00 p.m. PT. Cantor Global Healthcare Conference, September 9-11, 2026: Fireside chat will take place on Wednesday, September 9 at 2:45 p.m. ET \/ 11:45 a.m. PT. A live webcast of the fireside chats will be accessible through the Investors &amp; Media section of the Company&#8217;s website at https:\/\/investors.vaxcyte.com\/ for approximately 30 days following each conference. About Vaxcyte\u00a0 Vaxcyte &hellip; Continue reading &quot;Vaxcyte to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T20:08:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vaxcyte to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-08-27T20:08:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":417,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\",\"datePublished\":\"2026-08-27T20:08:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxcyte to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN CARLOS, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) &#8212; Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in fireside chats and host one-on-one meetings at the following investor conferences: Wells Fargo 21 st Annual Healthcare Conference, September 8-10, 2026: Fireside chat will take place on Tuesday, September 8 at 3:00 p.m. ET \/ 12:00 p.m. PT. Cantor Global Healthcare Conference, September 9-11, 2026: Fireside chat will take place on Wednesday, September 9 at 2:45 p.m. ET \/ 11:45 a.m. PT. A live webcast of the fireside chats will be accessible through the Investors &amp; Media section of the Company&#8217;s website at https:\/\/investors.vaxcyte.com\/ for approximately 30 days following each conference. About Vaxcyte\u00a0 Vaxcyte &hellip; Continue reading \"Vaxcyte to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-27T20:08:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vaxcyte to Participate in Upcoming Investor Conferences","datePublished":"2026-08-27T20:08:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":417,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/","name":"Vaxcyte to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=","datePublished":"2026-08-27T20:08:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTk1MiM3ODAyNjc4IzIxOTU4MjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxcyte-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vaxcyte to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998649"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998649\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}